Shun Xu

972 citations
22 papers · 712 indexed · h-index 14
Topics
MicroRNA in disease regulation (5 papers)Circular RNAs in diseases (5 papers)Cancer-related molecular mechanisms research (5 papers)
Partner nations
ChinaUnited States

In The Last Decade

Shun Xu

22 papers receiving 708 citations

Peers

Shun Xu
Comparison fields: 5 of 82
  • Molecular Biology 504
  • Cancer Research 224
  • Pathology and Forensic Medicine 173
  • Immunology 76
  • Public Health, Environmental and Occupational Health 61
Replace Yann Godfrin with:
Yann Godfrin France
Songou Zhang China
Maria-Grazia Spiga United States
Mingchen Xiong China
Jingya Miao United States
Jiaxing Wang China
Xingli Zhao China
Eun Ji Lee South Korea
Daniela Nascimento Silva Brazil
Shun Xu relative to Yann Godfrin France Yann Godfrin's profile →
Citations per field
00.5×3.0×
Yann Godfrin · 1×
Citations per year

Countries citing papers authored by Shun Xu

Since Specialization
Citations

This map shows the geographic impact of Shun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shun Xu more than expected).

Fields of papers citing papers by Shun Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shun Xu. The network helps show where Shun Xu may publish in the future.

Co-authorship network of co-authors of Shun Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Shun Xu. A scholar is included among the top collaborators of Shun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shun Xu. Shun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 2
3 67
4 3
5 88
6 56
7 19
8 24
9 5
10 28
11 16
12 6
13 13
14 33
15 4
16 48
17 21
18 16
19 38
20
[Expression of promyelocytic leukaemia protein in lung carcinomas and clinical significance thereof].
1

About Shun Xu

Shun Xu is a scholar working on Cancer Research, Pathology and Forensic Medicine and Molecular Biology, having authored 22 papers that have together received 712 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (5 papers). The work is most often cited by research in Cancer Research (224 citations), Pathology and Forensic Medicine (173 citations) and Molecular Biology (504 citations). Shun Xu has collaborated with scholars based in China and United States. Frequent co-authors include Minghao Shao, Xiaosheng Ma, Wei Zhu, Haocheng Xu, Fan Zhang, Jianyuan Jiang, Guangyu Xu, Chaojun Zheng, Xin Zhang and Yuxuan Zhang. Their work appears in journals such as Journal of Virology, Biochemical and Biophysical Research Communications and BioMed Research International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026